Tnt Based Diagnosis Of Paroxysmal Atrial Fibrillation - EP2917736

The patent EP2917736 was granted to F Hoffmann LA Roche on Dec 25, 2019. The application was originally filed on Nov 11, 2013 under application number EP13789010A. The patent is currently recorded with a legal status of "Revoked".

EP2917736

F HOFFMANN LA ROCHE
Application Number
EP13789010A
Filing Date
Nov 11, 2013
Status
Revoked
Jan 24, 2025
Publication Date
Dec 25, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MATHYS & SQUIRESep 25, 2020GRIFFINADMISSIBLE

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0648228
DESCRIPTIONUS5744305
DESCRIPTIONWO02083913
DESCRIPTIONWO02089657
DESCRIPTIONWO2012025355
INTERNATIONAL-SEARCH-REPORTWO2010007041
OPPOSITIONEP2002260
OPPOSITIONWO2004059293
OPPOSITIONWO2010017972
OPPOSITIONWO2013057135

Non-Patent Literature (NPL) Citations (83) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- AKAOGI, K. ET AL., PROC NATL ACAD SCI USA, (1996), vol. 93, pages 8384 - 8389
DESCRIPTION- ANDERSON, CIRCULATION RESEARCH, (1995), vol. 76, no. 4, pages 681 - 686
DESCRIPTION- "An introduction to stroke", Stroke Genetics, OXFORD UNIVERSITY PRESS, INCORPORATED
DESCRIPTION- "Biomarkers in Atrial Fibrillation: Investigating Biologic Plausibility, Cause, and Effect R. Becker", JOURNAL OF THROMBOSIS AND THROMBOLYSIS, (2005), vol. 19, no. 1, pages 71 - 75
DESCRIPTION- BUGNICOURT ET AL., EUR NEUROL, (2010), vol. 63, pages 24 - 28
DESCRIPTION- BURGER, A.M. ET AL., ONCOGENE, (1998), vol. 16, pages 2459 - 2467
DESCRIPTION- FERRIERES, CLINICAL CHEMISTRY, (1998), vol. 44, pages 487 - 493
DESCRIPTION- FUSTER V; RY- DEN LE; ASINGER RW ET AL., "ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiolo- gy/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferen", CIRCULATION, (20011023), vol. 104, no. 17, pages 2118 - 50
DESCRIPTION- HEERINGA ET AL., EUR HEART J., (2006), vol. 27, no. 8, page 949
DESCRIPTION- HIJAZI ET AL., CIRCULATION, (2012), vol. 125, pages 1605 - 1616
DESCRIPTION- HWA, V. ET AL., ENDOCR. REV, (1999), vol. 20, pages 761 - 787
DESCRIPTION- J. AM. COLL. CARDIOL., (2001), vol. 38, pages 2101 - 2113
DESCRIPTION- J. AM. COLL. CARDIOL., (2005), vol. 46, pages E1 - E82
DESCRIPTION- JONES, J.I. ET AL., ENDOCR. REV., (1995), vol. 16, pages 3 - 34
DESCRIPTION- KAMEL H. ET AL., CURR ATHEROSCLER REP, (2011), vol. 13, pages 338 - 343
DESCRIPTION- KARL, SCAND J CLIN LAB INVEST, (1999), vol. 230, pages 177 - 181
DESCRIPTION- LATINI ET AL., J INTERN MED., (201102), vol. 269, no. 2, pages 160 - 71
DESCRIPTION- LEVEY, ANNALS OF INTERNAL MEDICINE, (1999), pages 461 - 470
DESCRIPTION- MARCUS ET AL., HEART RHYTHM., (200802), vol. 5, no. 2, pages 215 - 21
DESCRIPTION- MASSON ET AL., CURR HEART FAIL REP, (2010), vol. 7, pages 15 - 21
DESCRIPTION- MOSES ET AL., PNAS USA, (1999), vol. 96, no. 6, pages 2645 - 2650
DESCRIPTION- MUELLER, CLIN CHEM LAB MED, (2004), vol. 42, pages 942 - 4
DESCRIPTION- NEEDLEMAN; WUNSCH, J. MOL. BIOL., (1970), vol. 48, page 443
DESCRIPTION- NOLAN, TRENDS BIOTECH- NOL., (2002), vol. 20, no. 1, pages 9 - 12
DESCRIPTION- OH, Y. ET AL., J. BIOL. CHEM., (1996), vol. 271, pages 30322 - 30325
DESCRIPTION- ONO, Y. ET AL., BIOCHEM BIOPHYS RES COMM, (1994), vol. 202, pages 1490 - 1496
DESCRIPTION- PEARSON ET AL., "Markers of Inflammation and Cardiovascular Disease", CIRCULATION, (2003), vol. 107, pages 499 - 511
DESCRIPTION- PEARSON; LIPMAN, PROC. NATL. ACAD. SCI. (USA, (1988), vol. 85, page 2444
DESCRIPTION- RIZOS ET AL., JOURNAL OF HUMAN HYPERTENSION, (2010), vol. 24, pages 447 - 457
DESCRIPTION- R. LATINI ET AL., J INTERN MED, (2011), vol. 269, pages 160 - 171
DESCRIPTION- SMITH, J ENDOCRINOL., (2000), vol. 167, pages 239 - 46
DESCRIPTION- SMITH; WATERMAN, ADD. APL. MATH., (1981), vol. 2, page 482
DESCRIPTION- SPRENGER, C.C. ET AL., CANCER RES, (1999), vol. 59, pages 2370 - 2375
DESCRIPTION- STCROIX, B. ET AL., SCIENCE, (2000), vol. 289, pages 1197 - 1202
DESCRIPTION- WACHTER ET AL., PLOS ONE, (2012), vol. 7, no. 4, page E34351
DESCRIPTION- WOO ET AL., J. BIOL. CHEM., (1985), vol. 260, no. 24, pages 13384 - 13388
DESCRIPTION- WU, CLIN CHEM, (2004), vol. 50, pages 867 - 73
DESCRIPTION- YEH, CIRCULATION, (2004), vol. 109, pages II-11 - II-14
DESCRIPTION- YEO, CLINICA CHIMICA ACTA, (2003), vol. 338, pages 107 - 115
DESCRIPTION- ZWEIG, CLIN. CHEM., (1993), vol. 39, pages 561 - 577
DESCRIPTION- R. LATINI ET AL., "Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-Atrial Fibrillation Trial", J INTERN MED, (2011), vol. 269, doi:doi:10.1111/j.1365-2796.2010.02287.x, pages 160 - 171, XP055048526
DESCRIPTION- ADAMS ET AL., "Guidelines for the Early Management of Adults With Ischemic Stroke, A Guideline From the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Qua", STROKE, (2007), vol. 38, doi:doi:10.1161/STROKEAHA.107.181486, page 1655, XP008150079
INTERNATIONAL-SEARCH-REPORT- GRIGORYAN S V ET AL, "Impact of inflammatory markers on pathogenesis and clinical outcomes at different types of atrial fibrillation", NEW ARMENIAN MEDICAL JOURNAL 2013 YEREVAN STATE MEDICAL UNIVERSITY ARM, (2013), vol. 7, no. 3, ISSN 1820-0254, pages 4 - 8, XP002719871 [XP] 1,4-9,11,20 * abstract * * page 6, column l, paragraph l - column r, paragraph 1; table 2 * [I] 2,3,10,12-14,22
INTERNATIONAL-SEARCH-REPORT- ÜLGEN A ET AL, "OP-054 THE RELATIONSHIP BETWEEN HSCRP LEVELS AND P WAVE DURATION IN LONE PAROXYSMAL ATRIAL FIBRILLATION PATIENTS", INTERNATIONAL JOURNAL OF CARDIOLOGY, (201303), vol. 163, no. 3, doi:10.1016/S0167-5273(13)70055-X, ISSN 0167-5273, XP028545593 [XP] 1,5-11,13,14 * abstract * [I] 2-4,12,22
INTERNATIONAL-SEARCH-REPORT- RIZOS I ET AL, "Hypertension and paroxysmal atrial fibrillation: a novel predictive role of high sensitivity C-reactive protein in cardioversion and long-term recurrence.", JOURNAL OF HUMAN HYPERTENSION JUL 2010, (201007), vol. 24, no. 7, ISSN 1476-5527, pages 447 - 457, XP009175989 [XD] 1,4-14,20 * abstract * * "Methods";; table 1 * * page 451, column r, paragraph 2 - paragraph 3 * * page 455, paragraph l * [I] 22
INTERNATIONAL-SEARCH-REPORT- R. LATINI ET AL, "Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-Atrial Fibrillation Trial", JOURNAL OF INTERNAL MEDICINE, (20110201), vol. 269, no. 2, doi:10.1111/j.1365-2796.2010.02287.x, ISSN 0954-6820, pages 160 - 171, XP055048526 [X] 1-14,20 * the whole document * [I] 22
INTERNATIONAL-SEARCH-REPORT- MASSON SERGE ET AL, "Predicting atrial fibrillation recurrence with circulating inflammatory markers in patients in sinus rhythm at high risk for atrial fibrillation: data from the GISSI atrial fibrillation trial", HEART, BRITISH CARDIAC SOCIETY, UK, (20101201), vol. 96, no. 23, doi:10.1136/HRT.2009.191460, ISSN 1468-201X, pages 1909 - 1914, XP009176038 [X] 1-3,5-9,20 * abstract * * page 1911, paragraph 4 *
INTERNATIONAL-SEARCH-REPORT- KIRCHHOF P ET AL, "Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options: Executive summary< *> of the report from the 3<rd> AFNET/EHRA consensus conference", THROMBOSIS AND HAEMOSTASIS 2011 SCHATTAUER GMBH DEU, (2011), vol. 106, no. 6, ISSN 0340-6245, pages 1012 - 1019, XP002719873 [A] 1-14,20,22 * abstract *
INTERNATIONAL-SEARCH-REPORT- NAOYUKI SATA ET AL, "C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation?", JAPANESE HEART JOURNAL, (20040501), vol. 45, no. 3, ISSN 0021-4868, pages 441 - 445, XP055101096 [X] 1-3,5-9,20 * abstract * * figures 1a, 1b *
INTERNATIONAL-SEARCH-REPORT- CHENG T ET AL, "Correlation between atrial fibrillation, serum amyloid protein A and other inflammatory cytokines", MOLECULAR MEDICINE REPORTS 2012 SPANDIDOS PUBLICATIONS LTD. GRC, (201209), vol. 6, no. 3, ISSN 1791-2997, pages 581 - 584, XP002719872 [X] 1,4-9,20 * abstract * [I] 2,3,10-14,22
OPPOSITION- APPLE et al., "Plasma 99th percentile Reference Limits for Cardiac troponin and Creatine Kinase MB Mass for Use with European Society of Cardiology/ American College of Cardiology Consensus Recommendations", Clin. Chem., (20030000), vol. 49, no. 8, pages 1331 - 1336, XP055275580
OPPOSITION- FEDERICO, "Natriuretic peptide system and cardiovascular disease", Heart Views, (20100000), vol. 11, pages 10 - 15, XP055740308
OPPOSITION- Giuseppe Boriani, Giovanni Luca Botto, Luigi Padeletti, Massimo Santini, Alessandro Capucci, Michele Gulizia, Renato Ricci, Mauro Biffi, Tiziana De Santo, Giorgio Corbucci, Gregory Y.H. Lip, "Improving Stroke Risk Stratification Using the CHADS2 and CHA2DS2-VASc Risk Scores in Patients With Paroxysmal Atrial Fibrillation by Continuous Arrhythmia Burden Monitoring", Stroke, (20110000), vol. 42, pages 1768 - 1770, XP055740409
OPPOSITION- John J You, Daniel E Singer , Patricia A Howard , Deirdre A Lane , Mark H Eckman , Margaret C Fang , Elaine M Hylek , Sam Schulman , Alan S Go , Michael Hughes , Frederick A Spencer , Warren J Manning , Jonathan L Halperin , Gregory Y H Lip, "Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines", Chest, (20120000), vol. 141, pages e531S - e575S, XP055740402
OPPOSITION- Kristen K Patton , Patrick T Ellinor, Susan R Heckbert, Robert H Christenson, Christopher DeFilippi, John S Gottdiener, Richard A Kronmal, "N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study", Circulation, (20090000), vol. 120, pages 1768 - 1774, XP055740327
OPPOSITION- Mcclatchey, Kenneth D., "Myocardial and skeletal muscle disease", Clin. Lab. Medicine, (20020000), pages 1 - 22, XP055740125
OPPOSITION- Michael J Conrad; Petr Jarolim, "Cardiac Troponins and High­ sensitivity Cardiac Troponin Assays", Clin. Lab. Med., (20140000), vol. 34, pages 59 - 73, XP055625696
OPPOSITION- Michiel Rienstra, Steven A. Lubitz, Saagar Mahida, Jared W. Magnani, João D. Fontes, Moritz F. Sinner, Isabelle C. Van Gelder, Patrick T. Ellinor, and Emelia J. Benjamin, "Symptoms and Functional Status of Patients With Atrial Fibrillation State of the Art and Future Research Opportunities", Circulation, (20120000), vol. 125, pages 2933 - 2943, XP055740424
OPPOSITION- SHAVE et al., "Exercise-Induced Cardiac Troponin Elevation", J. Am. Coll. Cardiol., (20100000), vol. 56, no. 3, pages 169 - 176, XP027130002
OPPOSITION- Gahlmann R; Wade R; Gunning P; Kedes L, "Differential expression of slow and fast skeletal muscle troponin C - Slow skeletal muscle troponin C is expressed in human fibroblasts", J. Mol. Biol., (19880000), vol. 201, no. 2, pages 379 - 391, XP024009812
OPPOSITION- Saenger A K; Beyrau R; Braun S; Cooray R; Dolci A; Freidank H; Giannitsis E; Gustafson S; Handy B; Katus H; Melanson S E; Panteghini M; Venge P; Zorn M; Jarolim P; Bruton D; Jarausch J; Jaffe A S, "Multicenter analytical evaluation of a high-sensitivity troponin T assay", Clinica Chimica Acta, (20110000), vol. 412, pages 748 - 754, XP028148110
OPPOSITION- PANTEGHINI, "Role and importance of biochemical markers in clinical cardiology", European Heart Journal, (20040000), vol. 25, pages 1187 - 1196, XP055275663
OPPOSITION- Jaffe; Babuin A S; Apple L; F S, "Biomarkers in Acute Cardiac Disease", J. Am. Coll. Cardiol., (20060000), vol. 48, pages 1 - 11, XP005519486
OPPOSITION- Lowbeer; Seeberger C; Gustafsson A; Bouvier S A; Hulting F; J, "Serum cardiac troponin T, troponin I, plasma BNP and left ventricular mass index in professional football players", Jour. Sci. Med. Sport, (20070000), vol. 10, no. 5, pages 291 - 296, XP022211854
OPPOSITION- Torbjørn Omland, Ph.D., James A. de Lemos, Marc S. Sabatine,M.P.H., Costas A. Christophi, Madeline Murguia Rice, Kathleen A. Jablonski, Solve Tjora, Michael J. Domanski, Bernard J. Gersh, M.B., Ch.B., D.Phil., Jean L. Rouleau, "A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease", N. Engl. J. Med., (20090000), vol. 361, pages 2538 - 2547, XP055740301
OPPOSITION- SUNDSTROM et al., "Cardiac troponin-I and risk of heart failure: a community-based cohort study", European Heart Journal, (20090000), vol. 30, pages 773 - 781, XP055051011
OPPOSITION- Thygesen K; Mair J; Katus H; Plebani M; Venge P; Collinson P; Lindahl B; Giannitsis E; Hasin Y; Galvani M; Tubaro M; Alpert J S; Biasucci L M; Koenig W; Mueller C; Huber K; Hamm C; Jaffe A S, "Recommendations for the use of cardiac troponin measurement in acute cardiac care", European Heart Journal, (20100000), vol. 31, pages 2197 - 2206, XP055413063
OPPOSITION- Camm A J; Kirchhof P; Lip G Y H; Schotten U; Savelieva I; Ernst S; Van Gelder I C; Al-Attar N; Hindricks G; Prendergast B; Heidbuchel H; Alfieri O; Angelini A; Atar D; Colonna P; De Caterina R; De Sutter J; Goette A; Gorenek B; Heldal M; Hohloser S H; Kolh P; J-Y Le Heuzey; Ponikowski P; Rutten F H; Vahanian A; Auricchio A; Bax J; Ceconi C; Dean V; Filippatos G; Funck-Brentano C; Hobbs R; Kearney P; Mcdonagh T; Popescu B A; Reiner Z; Sechtem U; Sirnes P A; Tendera M; Vardas P E; Widimsky P; Agladze V; Aliot E; Balabanski T; Blomstrom-Lundqvist C; Capucci A; Crijns H; Dahlof B; Folliguet T; Glikson M; Goethals M; Gulba D C; Ho S Y; Klautz R J M; Kose S; Mcmurray J; Perrone Filardi P; Raatikainen P; Salvador M J; Schalij M J; Shpektor A; Sousa J; Stepinska J; Uuetoa H; Zamorano J L; Zupan I, "Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)", Eur. Heart. J., (20100000), vol. 31, pages 2369 - 2429, XP055124167
OPPOSITION- Van Den Bos E J; Constantinescu A A; Van Domburg R T; Akin S; Jordaens L J; Kofflard M J M, "Minor elevations in troponin I are associated with mortality and adverse cardiac events in patients with atrial fibrillation", European Heart Journal, (20110000), vol. 32, pages 611 - 617, XP055029203
OPPOSITION- Kristian Thygesen, Johannes Mair, Evangelos Giannitsis, Christian Mueller, Bertil Lindahl, Stefan Blankenberg, Kurt Huber, Mario Plebani, Luigi M. Biasucci, Marco Tubaro, Paul Collinson, Per Venge, Yonathan Hasin, Marcello Galvani, Wolfgang Koenig, Christian Hamm, Joseph S. Alpert, Hugo Katus, Allan S. Jaffe, "How to use high-sensitivity cardiac troponins in acute cardiac care", European Heart Journal, (20120000), vol. 33, pages 2259 - 2257, XP055740123
OPPOSITION- ZELLER et al., "High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort", European Heart Journal, (20140000), vol. 35, pages 271 - 281, XP055275648
OPPOSITION- Paulus Kirchhof , Gregory Y H Lip, Isabelle C Van Gelder, Jeroen Bax, Elaine Hylek, Stefan Kaab, Ulrich Schotten, Karl Wegscheider, Giuseppe Boriani, Axel Brandes, Michael Ezekowitz, Hans Diener, Laurent Haegeli, Hein Heidbuchel, Deirdre Lane, Luis Mont, Stephan Willems, Paul Dorian, Maria Aunes-Jansson, Carina Blomstrom-Lundqvist, Maria Borentain, Stefanie Breitenstein, Martina Brueckmann, Nilo Cater, Andreas Clemens, Dobromir Dobrev, Sergio Dubner, Nils G Edvardsson, Leif Friberg, Andreas Goette, Michele Gulizia, Robert Hatala, Jenny Horwood, Lukas Szumowski, Lukas Kappenberger, Josef Kautzner, Angelika Leute, Trudie Lobban, Ralf Meyer, Jay Millerhagen, John Morgan, Felix Muenzel, Michael Nabauer, Christoph Baertels, Michael Oeff, Dieter Paar, Juergen Polifka, Ursula Ravens, Ludger Rosin, W Stegink, Gerhard Steinbeck, Panos Vardas, Alphons Vincent, Maureen Walter, Günter Breithardt, A John Camm, "Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference", Eurospace, (20120000), vol. 14, pages 8 - 27, XP055740416
OPPOSITION- Brugts Jasper J; Akin Sakir; Helming Anne-Mijntje; Loonstra Simone; van den Bos Ewout J; Kofflard Marcel J M, "The predictive value of cardiac biomarkers in prognosis and risk stratification of patients with atrial fibrillation", Curr. Opin. Cardiol., (20110000), vol. 26, no. 5, pages 449 - 456, XP008152363
OPPOSITION- Stephen S Cai; Bonds Brandon W; Hu Peter F; Stein Deborah M, "The role of cardiac troponin I in prognostication of patients with isolated severe traumatic brain injury", J. Trauma Acute Care Surg, (20160000), vol. 80, pages 477 - 483, XP055500993
OPPOSITION- Latini R; Masson S; Pirelli S; Barlera S; Pulitano G; Carbonieri E; Gulizia M; Vago T; Favero C; Zdunek D; Struck J; Staszewsky L; Maggioni A P; Franzosi M G; Disertori M, "Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-Atrial Fibrillation Trial", J. Intern. Med., (20110000), vol. 269, pages 160 - 171, XP055048526
OPPOSITION- Maynard S J; Menown And A A J Adgey I B A, "Troponin T or troponin I as cardiac markers in ischaemic heart disease", Heart, (20000000), vol. 83, pages 371 - 373, XP055625679
OPPOSITION- BUGNICOURT et al., "Troponin levels help predict new-onset atrial fibrillation in ischaemic stroke patients: a retrospective study", Eur. Neurol., (20091100), vol. 63, pages 24 - 28, XP008152374
OPPOSITION- LATINI et al., "Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure", Circulation, (20070000), vol. 116, pages 1242 - 1249, XP002458356
OPPOSITION- Ziad Hijazi, Jonas Oldgren, Ulrika Andersson, Stuart J. Connolly, Michael D. Ezekowitz, Stefan H. Hohnloser, Paul A. Reilly, Dragos Vinereanu, Agneta Siegbahn, Salim Yusuf, and Lars Wallentin, "Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy", Circulation, (20120000), vol. 125, pages 1605 - 1616, XP055740237
OPPOSITION- TATE et al., "The determination of the 99th centile level for troponin assays in an Australian reference population", Ann. Clin. Biochem., (20080000), vol. 45, pages 275 - 288, XP055275582
OPPOSITION- Rolf Wachter; Rosine Lahno; Beatrice Haase; Mark Weber-Krüger; Joachim Seegers; Frank Edelmann; Janin Wohlfahrt; Götz Gelbrich; Anke Görlitz; Pawel Kermer; Dirk Vollmann; Gerd Hasenfuß; Klaus Gröschel; Raoul Stahrenberg, "Natriuretic Peptides for the Detection of Paroxysmal Atrial Fibrillation in Patients with Cerebral Ischemia - the Find-AF Study", PLoS ONE, (20120000), vol. 7, no. 4, pages e34351, 1 - e34351,7, XP055435165
OPPOSITION- CADAMURO et al., "Cardiac troponins T and I: reproducible discrepancies in the clinical setting", Clin. Chem., (20110000), vol. 57, pages 134 - 140, XP055740219
OPPOSITION- Lieke J J Klinkenberg; Karin Wildi; Noreen Van Der Linden; Lmre W K Kouw; Marijke Niens; Raphael Twerenbold; Maria Rubini Gimenez; Christian Puelacher; Jean Daniel Neuhaus; Petra Hillinger; Thomas Nestelberger; Jasper Boeddingaus; Karin Grimm; Zaid Sabti; Judith A P Bons; Jeroen D E Van Suijlen; Frans E S Tan; Joop Ten Kate; Otto Bekers; Luc J C Van Loon; Marja P Van Dieijen-Visser; Christian Mueller; And Steven J R Meex, "Diurnal Rhythm of Cardiac Troponin: Consequences for the Diagnosis of Acute Myocardial Infarction", Clin. Chem., (20160000), vol. 62, pages 1602 - 1611, XP055625693

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents